PNC Financial Services Group
IRD

PNC Financial Services Group’s Opus Genetics IRD Stock Holding History

PNC Financial Services Group’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed – – 4769
2015
Q1 		$0 Buy
+1
New +$363 ﹤0.01% 4770

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

PNC Financial Services Group's IRD Position: Q2 2015 in Review

PNC Financial Services Group sold out of Opus Genetics (IRD) in Q2 2015, closing a stake of 1 share.

PNC Financial Services Group first reported a position in IRD in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 35 funds tracked by Wall St. Rank hold IRD as of Q2 2015.

  • PNC Financial Services Group reported no remaining Opus Genetics position as of Q2 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 1 Opus Genetics share in Q2 2015.
  • PNC Financial Services Group first reported a position in Opus Genetics in Q1 2015 and held it in 1 quarter.
  • PNC Financial Services Group's Opus Genetics position peaked at $0 in Q1 2015.
  • 35 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2015.

Based on PNC Financial Services Group's 13F filing for Q2 2015, filed 5 Aug 2015.